Julia Ritterhoff

2.4k total citations · 1 hit paper
28 papers, 1.5k citations indexed

About

Julia Ritterhoff is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Julia Ritterhoff has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Cardiology and Cardiovascular Medicine and 4 papers in Physiology. Recurrent topics in Julia Ritterhoff's work include Mitochondrial Function and Pathology (8 papers), S100 Proteins and Annexins (8 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Julia Ritterhoff is often cited by papers focused on Mitochondrial Function and Pathology (8 papers), S100 Proteins and Annexins (8 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Julia Ritterhoff collaborates with scholars based in United States, Germany and Japan. Julia Ritterhoff's co-authors include Rong Tian, Stephen C. Kolwicz, Patrick Most, Daniel Raftery, Haiwei Gu, Outi Villet, Bo Zhou, Hugo A. Katus, Dan Shao and Lauren Abell and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Julia Ritterhoff

26 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges

2023 114 citations Julia Ritterhoff, Rong Tian Nature Reviews Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Ritterhoff United States	18	1.0k	595	320	222	118	28	1.5k
Larissa Lipskaia France	23	1.1k 1.0×	474 0.8×	232 0.7×	201 0.9×	159 1.3×	57	1.8k
Tong Tang United States	26	1.1k 1.1×	575 1.0×	185 0.6×	160 0.7×	85 0.7×	59	1.7k
Jan Magnus Aronsen Norway	29	1.3k 1.2×	1.3k 2.3×	169 0.5×	173 0.8×	118 1.0×	88	2.2k
Xiaoying Zhang United States	21	968 0.9×	721 1.2×	118 0.4×	195 0.9×	70 0.6×	39	1.5k
Elie R. Chemaly United States	24	818 0.8×	949 1.6×	165 0.5×	279 1.3×	78 0.7×	39	1.8k
Sang‐Ging Ong United States	20	829 0.8×	320 0.5×	242 0.8×	128 0.6×	184 1.6×	41	1.4k
Antoine H. Chaanine United States	16	900 0.9×	675 1.1×	131 0.4×	132 0.6×	184 1.6×	28	1.5k
Ravi K. Adapala United States	19	599 0.6×	226 0.4×	266 0.8×	169 0.8×	130 1.1×	33	1.3k
Mary F. Walsh United States	25	595 0.6×	447 0.8×	391 1.2×	204 0.9×	96 0.8×	53	1.7k
Martha S. Lundberg United States	14	760 0.7×	356 0.6×	117 0.4×	156 0.7×	92 0.8×	21	1.2k

Countries citing papers authored by Julia Ritterhoff

Since Specialization

Citations

This map shows the geographic impact of Julia Ritterhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Ritterhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Ritterhoff more than expected).

Fields of papers citing papers by Julia Ritterhoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Ritterhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Ritterhoff. The network helps show where Julia Ritterhoff may publish in the future.

Co-authorship network of co-authors of Julia Ritterhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Ritterhoff. A scholar is included among the top collaborators of Julia Ritterhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Ritterhoff. Julia Ritterhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salatzki, Janek, Erhe Gao, Walter J. Koch, et al.. (2025). Cardiac-Targeted AAV5-S100A1 Gene Therapy Protects Against Adverse Remodeling and Contractile Dysfunction in Postischemic Hearts. Circulation Heart Failure. 18(7). e012479–e012479. 2 indexed citations

Brandt, Jason, Samuel Knoedler, Patrick Most, et al.. (2025). The burn repair molecule? Evaluating FGF-21 in thermal injury – A systematic review. Burns. 52(1). 107785–107785.

Seitz, Andreas, Martin Busch, Stéphanie Simon, et al.. (2024). S100A1’s single cysteine is an indispensable redox switch for the protection against diastolic calcium waves in cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 327(1). H275–H286. 3 indexed citations

Ritterhoff, Julia, Timothy S. McMillen, Gernot Poschet, et al.. (2024). ¹³C stable isotope tracing reveals distinct fatty acid oxidation pathways in proliferative versus oxidative cells. American Journal of Physiology-Cell Physiology. 328(1). C168–C178.

Nishi, Kiyoto, Lauren Abell, Bo Zhou, et al.. (2023). Branched-chain keto acids inhibit mitochondrial pyruvate carrier and suppress gluconeogenesis in hepatocytes. Cell Reports. 42(6). 112641–112641. 24 indexed citations

Ritterhoff, Julia & Rong Tian. (2023). Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges. Nature Reviews Cardiology. 20(12). 812–829. 114 indexed citations breakdown →

Zhou, Bo, Arianne Caudal, Xiaoting Tang, et al.. (2022). Upregulation of mitochondrial ATPase inhibitory factor 1 (ATPIF1) mediates increased glycolysis in mouse hearts. Journal of Clinical Investigation. 132(10). 32 indexed citations

Ritterhoff, Julia, Timothy S. McMillen, Outi Villet, et al.. (2021). Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts. Journal of Molecular and Cellular Cardiology. 158. 1–10. 27 indexed citations

Yang, Xiulan, Marita L. Rodriguez, Andrea Leonard, et al.. (2019). Fatty Acids Enhance the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells. Stem Cell Reports. 13(4). 657–668. 208 indexed citations

10.

Shao, Dan, Outi Villet, Zhen Zhang, et al.. (2018). Glucose promotes cell growth by suppressing branched-chain amino acid degradation. Nature Communications. 9(1). 2935–2935. 114 indexed citations

11.

Li, Tao, Zhen Zhang, Stephen C. Kolwicz, et al.. (2017). Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion Injury. Cell Metabolism. 25(2). 374–385. 300 indexed citations

12.

Shao, Dan, Outi Villet, Zhen Zhang, et al.. (2017). Glucose Promotes Cell Growth by Suppressing Branched-chain Amino Acid Degradation. Journal of Molecular and Cellular Cardiology. 112. 156–156. 10 indexed citations

13.

Ritterhoff, Julia, Mirko Völkers, Andreas Seitz, et al.. (2015). S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction. Molecular Therapy. 23(8). 1320–1330. 13 indexed citations

14.

Rohde, David, Melanie Boerries, Julia Ritterhoff, et al.. (2014). S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll‐like receptor 4. EMBO Molecular Medicine. 6(6). 778–794. 71 indexed citations

15.

Ritterhoff, Julia, Mirko Völkers, Andreas Seitz, et al.. (2014). Abstract 37: The Positive Inotropic S100a1 Prevents Arrhythmogenic Sarcoplasmic Reticulum Ca2+ Leak And Ventricular Arrhythmias. Circulation Research. 115(suppl_1). 1 indexed citations

16.

Neacșu, Ionela Andreea, Sven W. Sauer, Philip Raake, et al.. (2013). Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model. Gene Therapy. 21(2). 131–138. 31 indexed citations

17.

Ritterhoff, Julia & Patrick Most. (2012). Targeting S100A1 in heart failure. Gene Therapy. 19(6). 613–621. 37 indexed citations

18.

Raake, Philip, et al.. (2011). Gene Therapy Targets in Heart Failure: The Path to Translation. Clinical Pharmacology & Therapeutics. 90(4). 542–553. 19 indexed citations

19.

Rohde, David, Julia Ritterhoff, Mirko Voelkers, et al.. (2010). S100A1: A Multifaceted Therapeutic Target in Cardiovascular Disease. Journal of Cardiovascular Translational Research. 3(5). 525–537. 47 indexed citations

20.

Rohde, David, et al.. (2010). S100A1 gene therapy for heart failure: A novel strategy on the verge of clinical trials. Journal of Molecular and Cellular Cardiology. 50(5). 777–784. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact